Skip to Main Content

When it comes to making eye drops, one Chinese manufacturer failed to clearly see the rules for sterile manufacturing, according to the U.S. Food and Drug Administration.

Hubei Kangzheng was admonished by the regulator for a host of production lapses that could have led to microbial contamination in its Pi Yen Chin drops, according to a Nov. 23, 2021, warning letter that was posted on the agency web site this week.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment